Department of Cardiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
J Cardiovasc Electrophysiol. 2010 Apr;21(4):406-11. doi: 10.1111/j.1540-8167.2009.01645.x. Epub 2009 Nov 12.
There is a paucity of data on the success rates of achieving percutaneous epicardial access in different groups of patients.
Percutaneous epicardial access was attempted in 137 patients having 149 procedures; 19 patients had supraventricular tachycardia (SVT), 25 patients had idiopathic VT and 93 patients had scar-related ventricular tachycardia (VT). Ten patients had prior cardiac surgery. Successful epicardial access was achieved in 133 of 149 (89.3%) procedures. Access was achieved in 17 of 19 (89.5%) patients with SVT, all patients with idiopathic VT, 80 of 93 (86.0%) patients with scar-related VT and in 2 (20%) patients with prior cardiac surgery. Attempted access failed in 16 patients; 8 had prior cardiac surgery and 3 had prior pericarditis. After an initial procedure, repeat access was attempted in 15 patients, 5.1 +/- 5.4 months after initial epicardial mapping and ablation. Access was successful in 13 (86.7%) and failed in 2 patients who had pericarditis after their first procedure. Only 4 patients were given intrapericardial glucocorticoid at their first epicardial procedure. Prior cardiac surgery and a history of pericarditis predicted unsuccessful access (P < 0.01). Complications (9 patients) included pericardial bleeding (80-250 mL) and intraabdominal bleeding.
In patients without prior cardiac surgery, percutaneous epicardial access can be obtained in the majority of patients. Prior cardiac surgery precludes access in the most patients and when possible adhesions may limit catheter movement. Repeat access is possible in the majority of patients without the installation of intrapericardial glucocorticoid at the first procedure.
关于在不同患者群体中实现经皮心外膜入路的成功率的数据很少。
在 137 名患者的 149 例手术中尝试了经皮心外膜入路;19 名患者患有室上性心动过速(SVT),25 名患者患有特发性 VT,93 名患者患有瘢痕相关室性心动过速(VT)。10 名患者有既往心脏手术史。在 149 例手术中,有 133 例(89.3%)成功进行了心外膜入路。SVT 患者中有 17 例(89.5%)、所有特发性 VT 患者、瘢痕相关 VT 患者中的 80 例(86.0%)以及既往心脏手术患者中的 2 例(20%)均成功进行了心外膜入路。16 名患者尝试进行心外膜入路失败;其中 8 名有既往心脏手术史,3 名有既往心包炎史。在初始手术之后,在 15 名患者中尝试了重复心外膜入路,距初始心外膜标测和消融后 5.1±5.4 个月。13 例(86.7%)成功,2 例在首次手术后出现心包炎的患者失败。在首次心外膜手术中,仅 4 名患者接受了心包内糖皮质激素治疗。既往心脏手术和心包炎史预测心外膜入路失败(P<0.01)。并发症(9 名患者)包括心包出血(80-250 毫升)和腹腔内出血。
在没有既往心脏手术的患者中,大多数患者可以获得经皮心外膜入路。既往心脏手术使大多数患者无法获得入路,而且在可能的情况下,粘连可能限制导管的运动。在大多数患者中,无需在首次手术时植入心包内糖皮质激素即可再次获得入路。